Recombinant respiratory syncytial vrus vaccine ( Advaccine Biotechnology)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRecombinant respiratory syncytial vrus vaccine ( Advaccine Biotechnology)
Drug Alias Name重组呼吸道合胞病毒疫苗（艾棣维欣）BARS-13OPN-003ADV110
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou Aidi Weixin Biotechnology Company
China Registration ClassN/A

Develop Information

Active CompaniesAdvaccine(Suzhou) Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A